Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
22.87
-0.68 (-2.89%)
May 22, 2026, 4:00 PM EDT - Market closed
Evommune Market Cap
Evommune has a market cap or net worth of $823.74 million as of May 22, 2026.
Market Cap
823.74M
Enterprise Value
621.39M
1-Year Change
n/a
Ranking
Category
Stock Price
$22.87
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $823.74M, an increase of 71.17%. That is a compound annual growth rate of 172.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 848.23M | 57.17% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cullinan Therapeutics | 850.58M |
| Theravance Biopharma | 843.92M |
| Xencor | 838.54M |
| Aura Biosciences | 838.28M |
| Omeros | 829.42M |
| Odyssey Therapeutics | 825.55M |
| Bright Minds Biosciences | 825.09M |
| Geron | 821.15M |